PHARMACEUTICAL COMPOSITIONS COMPRISING 2-(2-((RHO-CHLORO-ALPHA-METHYL-ALPHA-PHENYLBENZYL)OXY) ETHYL)-1-METHYLPYRROLIDINE

摘要

The invention concerns novel combinations of active agents a) 1-methyl-2-[2-( alpha -methyl-p-chlorodiphenylmethyloxy)ethyl]pyrrolidine and b) a non-toxic sympathicomimetic agent having a peripheral vasoconstrictive effect, useful in the treatment of rhinitis.